Propranolol Recall: Which Lot Is Affected and What to Do
Breckenridge has recalled one lot of propranolol extended-release 60 mg capsules over possible metal contamination. Which lot is affected, what to do if yours matches, and why you should not simply stop taking it.
- Written by
- Health Daily Advice
- Published
- Reading time
- 6 minutes
- Sources
- 6 cited
In this guide
One lot of Breckenridge propranolol extended-release 60 mg capsules — lot PK25110035, expiry May 2029 — has been recalled across the United States over possible metal contamination. If your bottle matches all four identifiers, stop taking those capsules and contact your doctor or pharmacist the same day for a replacement; do not simply stop treatment.
Which propranolol is being recalled?
Breckenridge Pharmaceutical announced the voluntary recall on 16 November 2026, and the US Food and Drug Administration (FDA) published it on 20 November 2026. Only one lot of one strength is affected. Check all four details on your bottle or packaging — all of them must match for the medicine to be part of this recall:
| Detail | Recalled product |
|---|---|
| Medicine | Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg |
| Lot number | PK25110035 |
| National Drug Code (NDC) | 51991-817-01 |
| Expiry date | May 2029 |
| Pack size | 100-count bottle |
| Company | Breckenridge Pharmaceutical, Inc. (made by Adare Pharma Solutions) |
The affected lot was distributed nationwide to wholesalers and pharmacies between 26 October and 4 November 2026. Other lots and other strengths of propranolol are not included in this recall. The FDA announcement does not state how many bottles were involved, so no figure should be assumed.

Why was it recalled?
The recall is precautionary and is due to potential metal contamination. According to the FDA announcement, the affected lot shared intermediate material suspected to be the source of metal contamination found in a separate lot that was never released for sale. The company therefore recalled this lot as well, because it may also be affected.
The FDA’s risk statement is specific: use of a product from the affected lot “could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine” — in other words, a metal fragment, if swallowed, could cut soft tissue in the mouth, gullet, stomach or intestine. The FDA does not state what type of metal, how large any fragment might be, or how many capsules could be affected, and those details should not be guessed at. Breckenridge said it was not aware of any adverse events assessed as related to this recall when it announced it.
What is propranolol?
Propranolol belongs to a group of medicines called beta blockers. It works by relaxing blood vessels and slowing the heart rate to improve blood flow and lower blood pressure. The NHS describes it as a medicine for heart problems, anxiety and migraine: it treats high blood pressure and irregular heartbeats such as atrial fibrillation, helps prevent future heart disease, heart attacks and strokes, and helps prevent chest pain caused by angina. It is also used to prevent migraines and to help with some of the physical symptoms of anxiety, such as a fast heart rate, sweating and shaking, by blocking the effects of adrenaline and noradrenaline.
Propranolol is prescription-only and comes as tablets, slow-release capsules or a liquid. The extended-release capsule is taken once a day and must be swallowed whole — never split, chewed or crushed. As MedlinePlus, the US National Library of Medicine’s patient service, puts it, propranolol “helps control your condition but will not cure it”, which is why people usually take it long term. Around 10 million people in the United States are prescribed propranolol, according to reports of this recall.
What to do if you take propranolol
If you take propranolol extended-release capsules, work through these steps:
- Check the bottle. Compare the medicine name, strength (60 mg), lot number (PK25110035), NDC (51991-817-01) and expiry (May 2029) with the table above. Only a bottle matching all four is recalled.
- If it matches, stop taking capsules from that lot and contact your doctor or pharmacist the same day for medical advice and replacement instructions, as the FDA directs.
- Return any unused capsules from the affected lot to the pharmacy where you got them.
- If you cannot find the lot number — for example, because the capsules were moved into a different container — contact the pharmacy that filled your prescription and ask whether it came from the recalled lot.
- Questions about the recall: contact Qualanex, Breckenridge’s recall service provider, on 1-855-736-0807 (Monday to Friday, 9 a.m. to 5 p.m. Eastern Time) or by email at recall@qualanex.com.
- Report a problem: if you have had a reaction or a quality problem that may be related, contact your doctor and report it to the FDA’s MedWatch programme, online or on 1-800-332-1088.
Pharmacies and wholesalers are being asked to check their stock for the recalled lot, quarantine any affected product and not distribute or dispense it.
Why you must not just stop taking it
This is the part of the story that needs care. The FDA says to stop taking capsules from the recalled lot immediately — but the general rule for beta blockers is never to stop suddenly without medical advice. Both are true, and the safe way through is to stop the recalled capsules and get a replacement the same day, rather than leaving the condition untreated.
The reason is spelled out in the FDA-approved labelling for propranolol: there have been reports of angina getting worse and, in some cases, heart attacks following abrupt discontinuation of propranolol therapy. When stopping is planned, the dose should be reduced gradually over at least a few weeks, and patients should be cautioned against interrupting or stopping therapy without their doctor’s advice. MedlinePlus gives the same warning in plainer terms: “Do not stop taking propranolol without talking to your doctor. If you suddenly stop taking propranolol, you may experience serious heart problems.”
The NHS adds that stopping suddenly after taking it for a long time can also bring extra side effects as a reaction, including an irregular heart rate, sweating and shaking, and that the effects of stopping can last for up to a week even though the drug itself leaves the body in about one to two days. The same caution applies to people given propranolol for other reasons, such as migraine or anxiety, because hidden coronary artery disease may be present without symptoms. In short: treat the recall seriously, but get your replacement sorted before you run out.
A second beta-blocker recall this month
Propranolol is not the only beta blocker recalled in November 2026. On 27 October, Advagen Pharma began recalling 3,684 bottles of metoprolol tartrate 50 mg tablets (lot 2611C065A1, expiry May 2028, NDC 72888-210-00) because they may contain foreign tablets or capsules. The FDA listed the recall in its weekly enforcement report in mid-November and classified it as Class II, meaning the product may cause temporary or medically reversible adverse health consequences, or the chance of serious harm is remote.
The metoprolol recall is harder for patients to spot, because the bottles are 1,000-count pharmacy bulk bottles that are counted out into smaller patient containers — most patients never see the original lot number. The surest check is to ask the dispensing pharmacy whether the prescription was filled from the affected lot, and not to take any tablet that looks different from the rest in size, colour, shape or markings without calling the pharmacy first. As with propranolol, metoprolol should not be stopped suddenly. The two recalls are separate events involving different companies and different problems, but together they are a reminder to check any new bottle against the label details — and to keep the pharmacy’s number handy.
When to see a doctor
Contact your doctor or pharmacist the same day if your propranolol matches the recalled lot, or if you have taken capsules from it and develop pain when swallowing, stomach pain, vomiting blood, or black stools — symptoms that could suggest an internal injury. Seek urgent help straight away if you develop chest pain, severe breathlessness, fainting, or signs of a stroke such as face drooping, arm weakness or slurred speech.
In an emergency call 911 (US), 999 (UK) or 112 (EU). If you are unsure whether your medicine is affected, your pharmacist can check the lot number for you — that is the quickest and safest route.
Frequently asked questions
How do I know if my propranolol is recalled?
Check all four details on the bottle: Breckenridge Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, lot number PK25110035, NDC 51991-817-01 and expiry May 2029. Only a bottle matching all four is part of the recall; other lots and strengths are not affected.
What should I do if my lot is affected?
Stop taking capsules from the recalled lot and contact your doctor or pharmacist the same day for a replacement. Return any unused capsules to the pharmacy where you got them. For questions about the recall, call Qualanex on 1-855-736-0807, Monday to Friday, 9 a.m. to 5 p.m. Eastern Time.
Is it dangerous to stop propranolol suddenly?
Yes. Stopping a beta blocker suddenly can make angina worse and, in some cases, has been linked to heart attacks, so the dose is normally reduced gradually over at least a few weeks. That is why the recall advice is to stop the affected capsules and get a replacement the same day, not to leave the condition untreated.
What harm could metal in a capsule cause?
According to the FDA, metal fragments in a capsule could potentially cause cuts to soft tissues in the mouth, gullet, stomach or intestine if swallowed. No injuries had been reported as linked to this recall when it was announced, and the recall is precautionary.
Does the recall affect all propranolol?
No. Only one lot of Breckenridge propranolol extended-release 60 mg capsules is recalled. Other lots, other strengths and propranolol made by other companies are not part of this recall, so do not stop a different product because of this news.
What if I cannot find the lot number?
If the capsules were moved into another container and the lot number is lost, contact the pharmacy that filled your prescription and ask whether it came from lot PK25110035. The pharmacy can check its records and tell you whether your medicine is affected.
Sources
- FDA: Breckenridge Pharmaceutical recall of one lot of propranolol extended-release capsules, 60 mg www.fda.gov
- MedlinePlus (US National Library of Medicine): Propranolol medlineplus.gov
- NHS: Common questions about propranolol www.nhs.uk
- DailyMed (FDA label): Propranolol Hydrochloride tablets dailymed.nlm.nih.gov
- AARP: Propranolol Recalled Over Potential Metal Contamination www.aarp.org
- Medical Daily: Advagen Recalls 3,684 Bottles of Metoprolol Tartrate 50 mg www.medicaldaily.com
Try the tool
Not sure if it can wait?
Common causes and warning signs for 16 everyday symptoms.
Open the symptom guide

